Maximus, Inc. (NYSE:MMS) declared a quarterly dividend on Thursday, October 12th, RTT News reports. Stockholders of record on Wednesday, November 15th will be given a dividend of 0.045 per share by the health services provider on Thursday, November 30th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date is Tuesday, November 14th.
Maximus has a dividend payout ratio of 5.8% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Maximus to earn $3.22 per share next year, which means the company should continue to be able to cover its $0.18 annual dividend with an expected future payout ratio of 5.6%.
Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.76 by $0.03. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm had revenue of $600.40 million during the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the previous year, the company earned $0.79 earnings per share. The firm’s quarterly revenue was down 2.7% on a year-over-year basis.
In related news, Director Paul R. Lederer sold 2,200 shares of the business’s stock in a transaction that occurred on Monday, August 14th. The shares were sold at an average price of $60.87, for a total transaction of $133,914.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Bruce Caswell sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $60.97, for a total transaction of $487,760.00. Following the sale, the president now owns 35,904 shares of the company’s stock, valued at $2,189,066.88. The disclosure for this sale can be found here. Insiders have sold 151,403 shares of company stock valued at $9,354,041 over the last 90 days. 3.10% of the stock is currently owned by company insiders.
Several research analysts have recently weighed in on MMS shares. Zacks Investment Research raised shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective for the company in a report on Wednesday, October 4th. BidaskClub cut shares of Maximus from a “strong-buy” rating to a “buy” rating in a report on Thursday, July 6th. Robert W. Baird reissued a “hold” rating and set a $64.00 price objective on shares of Maximus in a report on Friday, September 1st. Canaccord Genuity cut shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective for the company. in a report on Tuesday, July 4th. Finally, Maxim Group set a $66.00 price objective on shares of Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating and nine have given a hold rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $63.14.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.